Fas Apoptosis Inhibitory Molecule (FAIM) A Novel Gene that Inhibits Apoptosis

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		98-18
IP Type:		Licensable Technology
Title:		Fas Apoptosis Inhibitory Molecule (FAIM) A Novel Gene that Inhibits Apoptosis
Inventor:		Rothstein, Thomas L.
Summary:		This invention generally relates to the nucleic acid sequences of a novel gene called the Fas Apoptosis Inhibitory Molecule (faim) that encodes an apoptosis inhibiting protein. Furthermore, this invention relates to methods of identifying and testing antagonists of FAIM activity and to methods to assay for FAIM expression. This has important applications in enhancing desired immune responses such as those that follow vaccination or that might ameliorate malignant diseases, and in diminishing unwanted immune responses such as those responsible for autoimmune dyscrasias.
Tech Type:		Drug Discovery Tools
URL:		http://ctf-fmfe.bu.edu/BU9818.pdf
Contact:		Rick T. Clark, rclark@bu.edu, 617 358 4208
Organization:		Boston University

Display all intellectual properties for Rothstein, Thomas L.
Display all intellectual properties for Boston University